Poor obstetric outcome in subsequent pregnancies in women with prior fetal death

Obstetrics and Gynecology

Volumn 104, Issue 3, 2004, Pages 521-526

  Frias Jr , Antonio E ^b   Luikenaar, Rixt A ^b   Sullivan, Amy E ^b   Lee, Richard M ^b   Porter, T Flint ^b   Branch, D Ware ^b   Silver, Robert M ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PHOSPHOLIPID ANTIBODY;

ADULT; ARTICLE; FEMALE; FETUS DEATH; FIRST TRIMESTER PREGNANCY; HIGH RISK POPULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MATERNAL AGE; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SPONTANEOUS ABORTION; COHORT ANALYSIS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; RISK FACTOR;

ABORTION, SPONTANEOUS; ADULT; COHORT STUDIES; FEMALE; FETAL DEATH; HUMANS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 16244397034     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000137350.89939.2a     Document Type: Article

References (29)

1. Warburton D, Fraser FC. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. Am J Hum Genet 1964;16:1-25.
2. Poland BJ, Miller JR, Jones DC, Trimble BK. Reproductive counseling in patients who have had a spontaneous abortion. Am J Obstet Gynecol 1977;127:685-91.
3. Lee RM, Silver RM. Recurrent pregnancy loss: summary and clinical recommendations. Semin Reprod Med 2000;18:433-40.
4. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996;87:489-93.
5. Branch DW, Silver RM. Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss? Lupus 1996;5:409-13.
6. Martin BA, Branch DW, Rodgers GM. The preparation of a sensitive partial thromboplastin reagent from bovine brain. Blood Coagul Fibrinolysis 1992;3:287-94.
7. Harris EN. Special report. The Second International Anticardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. Am J Clin Pathol 1990;94:476-84.
8. Wilson WA, Gharavi AE, Piette JC. International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium. Lupus 2001;10:457-60.
9. Silver RM, Porter TF, van Leeuween I, Jeng G, Scott JR, Branch DW. Anticardiolipin antibodies: clinical consequences of "low titers". Obstet Gynecol 1996;87:494-500.
10. Harris EN, Chan JK, Asherson RA, Aber VR, Gharavi AE, Hughes GR. Thrombosis, recurrent fetal loss, and thrombocytopenia: predictive value of the anticardiolipin antibody test. Arch Intern Med 1986;146:2153-6.
11. Rai RS, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995;10:3301-4.
12. Warburton D, Fraser FC. On the probability that a woman who has had a spontaneous abortion will abort in subsequent pregnancies. J Obstet Gynaecol Br Emp 1961;68:784-8.
13. Regan L. Recurrent miscarriage. BMJ 1991;302:543-4.
14. Regan L, Braude PR, Trembath PL. Influence of past reproductive performance on risk of spontaneous abortion. BMJ 1989;299:541-5.
15. Goldenberg RL, Mayberry SK, Copper RL, Dubard MB, Hauth JC. Pregnancy outcome following a second-trimester loss. Obstet Gynecol 1993;81:444-6.
16. Preston EE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-6.
17. Boue J, Bou A, Lazar P. Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions. Teratology 1975;12:11-26.
18. Warburton D. Chromosomal causes of fetal death. Clin Obstet Gynecol 1987;30:268-77.
19. Coulam CB, Clark DA, Beer AE, Kutteh WH, Silver R, Kwak J, et al. Current clinical options for diagnosis and treatment of recurrent spontaneous abortion. Clinical Guidelines Recommendation Committee for Diagnosis and Treatment of Recurrent Spontaneous Abortion. Am J Reprod Immunol 1997;38:57-74.
20. Fretts RC, Schmittdiel J, McLean EH, Usher RH, Goldman MB. Increased maternal age and the risk of fetal death. N Engl J Med 1995;333:953-7.
21. Ahlenius I, Floberg J, Thomassen P. Sixty-six cases of intrauterine fetal death: a prospective study with an extensive test protocol. Acta Obstet Gynecol Scand 1995;74:109-17.
22. Rai R, Regan L, Hadley E, Dave M, Cohen H. Second-trimester pregnancy loss is associated with activated C resistance. Br J Haematol 1996;92:489-90.
23. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy [published erratum appears in N Engl J Med 1999;341:384]. N Engl J Med 1999;340:9-13.
24. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy [published erratum appears in N Engl J Med 1999;341:384]. N Engl J Med 1999;340:9-13.
25. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000;343:1015-8.
26. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992;80:614-20.
27. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997;314:253-7.
28. Saade GR, McLintock C. Inherited thrombophilia and stillbirth. Semin Perinatal 2002;26:51-69.
29. Lindqvist PG, Svensson PJ, Marsaal K, Grennert L, Luterkort M, Dahlback B. Activated protein C resistance (FV: Q506) and pregnancy. Thromb Haemost 1999;81:532-7.